Clinical Trials Logo

Filter by:
NCT ID: NCT00347464 Withdrawn - Clinical trials for Klinefelter Syndrome

Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome

Start date: June 2006
Phase: N/A
Study type: Observational

Klinefelter syndrome, a congenital chromosomal abnormality with one or more extra X chromosomes, occurs in out of 400 live male births. The majority of Klinefelter men present with a 47, XXY karyotype. The "poly-X variant", with the 49,XXXXY karyotype is uncommon. This syndrome, where subjects have two or more X chromosomes presents with primary hypogonadism, and, particularly if associated with the 49,XXXXY karyotype, significantly impacts life skills across a variety of dimensions, including areas of communication, community use, functional academics, home/school living, health and safety, leisure, self-care, self direction, and work. Adaptive behavior abnormalities in 46,XXY men are well known and described. In the poly-X variant of the 49,XXXXY karyotype, adaptive behavior abnormalities are expected to be much more significant, making these patients eligible for services and Social Security benefits. In 49,XXXXY men no study to date has examined these areas of inquiry in a large patient population, using a psychometrically sound instrument in a large patient population. Current publications are limited to individual case reports or small case summaries. It is important to study the adaptive behavior in its highly abnormal presentation in 49,XXXXY men in order to learn more about the effect of additional X chromosomes on adaptive skills, which determine how an individual responds to daily demands and in order to develop treatment and training goals.

NCT ID: NCT00346879 Withdrawn - Morbid Obesity Clinical Trials

Study to Determine Effective Dosing of Fondaparinux in Obese Persons

Start date: August 2006
Phase: Phase 1
Study type: Interventional

This is a prospective open-label study comparing two dosing regimens of fondaparinux, which is used to prevent deep vein thrombosis, in morbidly obese volunteers.

NCT ID: NCT00346502 Withdrawn - Clinical trials for Dysplastic Nevus Syndrome

Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)

Start date: January 2006
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of an experimental 20% betulinic acid ointment (BA ointment) as a treatment for dysplastic nevi with the potential to transform into melanoma.

NCT ID: NCT00346177 Withdrawn - Clinical trials for Cardiovascular Disease

Stem Cell Study for Patients With Heart Failure

Start date: September 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if cell therapy with your own cells (autologous cells) delivered with a catheter to regions of the heart with poor blood flow will be safe and if it will improve your ejection fraction and heart failure symptoms.

NCT ID: NCT00345111 Withdrawn - Clinical trials for Refractive Assessment

ACRYSOF® Restor Apodized Diffractive IOL Postmarket Evaluation of Clinical Outcomes and Life-Style Visual Performance RESTOR IOL SN60WF IOL (Control Group)

Start date: July 2005
Phase: Phase 4
Study type: Interventional

The objective of the research on the Restore Intra Ocular Lens Implant (IOL) is to determine the clinical visual outcomes following bilateral implantation of the IOL compared to a control IOL and to demonstrate what percentage of the subjects obtain spectacle freedom.

NCT ID: NCT00345020 Withdrawn - Clinical trials for Corneal Transplantation

Deep Lamellar Endothelial Keratoplasty: Small Incision Technique

Start date: May 2006
Phase:
Study type: Observational

The research objectives of this study are to determine if small incision Deep Lamellar Endothelial Keratoplasty (DLEK) is able to further reduce the degree of corneal astigmatism and shorten the time course of corneal topography stabilization compared to standard full thickness corneal transplant (PKP) surgery.

NCT ID: NCT00344708 Withdrawn - Clinical trials for Corneal Epithelial Dystrophy

Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces

Start date: September 2000
Phase: N/A
Study type: Interventional

To investigate the effect of using tissue cultured human amniotic epithelial cells to re-establish severely damaged ocular surfaces. Specifically, to determine the efficacy of transplanted tissue cultured amniotic epithelial cells on persistent corneal epithelial defect, a potential visual threaten ocular disorder.

NCT ID: NCT00344097 Withdrawn - Pain Clinical Trials

The Effects of Soy Protein on Post-thoracotomy Pain

Start date: March 2006
Phase: Phase 2
Study type: Interventional

This study seeks to determine whether soy protein supplements reduce the pain that often occurs following surgery for a lung tumor. Patients are randomized to receive either soy protein or milk protein prior to and following a thoracotomy for a lung tumor. We are especially interested in pain severity and pain medication use following surgery and will measure function and quality of life.

NCT ID: NCT00343759 Withdrawn - Breast Cancer Clinical Trials

Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy

Start date: June 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to see what kinds of breast tumors will respond to lapatinib. Lapatinib is an experimental medicine which may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.